Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Metrics Regulatory News (OMG)

Share Price Information for Oxford Metrics (OMG)

Share Price is delayed by 15 minutes
Get Live Data
46.10    -1.20 (-2.54%)
Bid:
46.10
Ask:
47.90
Spread: 1.80 (3.905%)
Market Cap: £51.60m
OMG Live PriceLast checked at - London Stock Exchange

Intraday Oxford Metrics Share Chart

AGM Statement

25 Feb 2026 07:00

RNS Number : 2489U
Oxford Metrics PLC
25 February 2026
 

25 February 2026

 

Oxford Metrics plc

("Oxford Metrics" or the "Group")

 

AGM Statement

 

Oxford Metrics plc (LSE: OMG), the smart sensing and software company servicing life sciences, entertainment, engineering and smart manufacturing markets, issues the following trading update ahead of its Annual General Meeting later today.

 

As announced on 16 December 2025, the Group has changed its accounting reference date to 31 December. FY26 will cover the 15-month period ending 31 December 2026. This update provides details on the Group's trading since 1 October 2025.

 

Current Trading

The Group has seen solid trading momentum across both divisions and continues to make progress against its strategic priorities, with encouraging operational progress. Management remains focused on delivery and on improving profitability as well as revenue growth.

 

Motion Capture

 

In Motion Capture, the Group's focus on the highest-return opportunities and accelerating growth in emerging markets is progressing well, supported by broadening technology adoption across new industry applications, the Group's previous introduction of innovative, accessible product solutions and strong brand leadership.

 

During the period, Vicon, the Motion Capture division trading brand, secured two large Entertainment orders totalling £2.7 million from customers in Eastern Europe and Japan, further stage extension orders in China and two turnkey Life Sciences contracts in India. In the United States, the opportunity pipeline and market activity is similar to the same period 12 months ago.

 

In Markerless technology, the pipeline has continued to grow in value and customer interest remains strong across geographies, driven by its lower cost of ownership, ease of use and versatile application potential. The Group's focus is on improving conversion rates, supported by planned product updates throughout the financial year that are intended to broaden use cases - including into Life Sciences - and accelerate adoption, unlocking new software-based, recurring revenue opportunities.

 

Smart Manufacturing

 

In Smart Manufacturing, the Group's focus on high-precision vision inspection, metrology and automation for blue-chip manufacturers is reflected in the business secured during the period as customers invest to enhance accuracy, reduce waste, and accelerate production throughput.

 

The division delivered multiple metrology product orders for a leading UK multinational engineering group and repeat business from a global food and beverage supplier, and secured vision inspection systems for medical vials, surgical blades, industrial laboratory diamonds, and advanced semiconductors.

 

As previously announced, Sempre and IVS will be unified from 1st March 2026 as Industrial Vision and Metrology Systems Limited (IVMS). This is intended to strengthen execution, improve order-to-revenue conversion, increase efficiency and synergies, and support margin improvement as the Group progresses this division towards a more scalable, product-led model.

 

Outlook

 

The Group continues to evaluate M&A opportunities aligned with its long-term strategy across both divisions, maintaining a disciplined approach.

 

The Board remains confident in delivering further progress through FY26, supported by growing pipelines, planned Motion Capture product launches and the benefits of unifying the Smart Manufacturing division.

 

As previously indicated, the Board expects to set out the Group's refined strategy, including detail on capital allocation within the three-year framework, within FY26 and will provide further detail in due course.

 

Imogen O'Connor, CEO of Oxford Metrics, commented:

 

"The financial year to date has seen solid trading in both our divisions, alongside pleasing operational progress across the Group. In Motion Capture, we are seeing good activity in the markets we are prioritising, and our focus is on converting pipeline into revenue. In the United States, market conditions are largely unchanged, and we continue to navigate this market carefully. In Smart Manufacturing, we are securing business in the sectors we have targeted. The formation of IVMS marks an important step in building a more efficient, scalable operation, positioning the division well for the future. Looking ahead, we remain focused on delivery and on building a more predictable, profitable platform for growth, and look forward to updating shareholders on our strategy for the next phase in FY26."

 

 

Contacts

Oxford Metrics

+44 (0)1865 261 860

Imogen O'Connor, CEO

Zoe Fox, CFO

Panmure Liberum (NOMAD & Broker)

+44 (0)20 3100 2000

James Sinclair-Ford / Rupert Dearden / Gaya Bhatt

Alma Strategic Communications

+44 (0)20 3405 0205

Hilary Buchanan / Rebecca Sanders-Hewett / David Ison / Kinvara Verdon

oxfordmetrics@almastrategic.com

 

 

About Oxford Metrics

 

Oxford Metrics (LSE:OMG) is a smart sensing and measurement technology Group that serves thousands of customers in more than 70 countries. Founded in 1984, we started our journey in healthcare, expanded into entertainment, winning an OSCAR® and an Emmy®, moved into engineering and more recently, smart manufacturing. We have a strong track record of creating value by incubating, growing, and then augmenting through acquisition, unique technology businesses.

 

The Group trades through two divisions; in motion capture its market-leading company Vicon Motion Systems provides motion measurement analysis to thousands of customers worldwide in healthcare, entertainment, and engineering markets. In Smart Manufacturing, Industrial Vision Systems is a specialist in machine vision software and technology for high precision, automated quality control systems trusted by blue-chip, smart manufacturing companies in medical devices, pharmaceuticals, and performance engineering. Sempre is a measurement specialist solving manufacturing challenges across aerospace, automotive, medical device, and precision engineering markets.

 

The Group is headquartered in Oxford with offices in the United Kingdom, Ireland, United States and Germany.

 

For more information about Oxford Metrics, visit www.oxfordmetrics.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMUSSKRNVUUUAR
Date   Source Headline
23rd Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 20267:00 amRNSTransaction in Own Shares
29th Jan 20267:00 amRNSTransaction in Own Shares
28th Jan 20267:00 amRNSTransaction in Own Shares
27th Jan 20267:00 amRNSTransaction in Own Shares
26th Jan 20267:00 amRNSTransaction in Own Shares
15th Jan 202611:23 amRNSGrant of LTIP Award to Directors
8th Jan 20269:10 amRNSTotal Voting Rights
19th Dec 20259:33 amRNSPosting of Annual Report & Notice of AGM
19th Dec 20259:33 amRNSPosting of Annual Report & Notice of AGM
19th Dec 20257:00 amRNSGrant of LTIP Award to Directors
19th Dec 20257:00 amRNSGrant of LTIP Award to Directors
16th Dec 202510:48 amRNSChange in Accounting Reference Date
12th Dec 20255:19 pmRNSNotification of Transactions by a PDMR
12th Dec 202512:42 pmRNSNotification of Transactions by a PDMR
10th Dec 20253:27 pmRNSNotification of major holdings
9th Dec 20252:43 pmRNSNotification of Transactions by a PDMR
9th Dec 202512:10 pmRNSNotification of Transactions by a PDMR
9th Dec 202510:15 amRNSNotification of Transactions by a PDMR and a PCA
9th Dec 20257:00 amRNSAudited Preliminary Results
9th Dec 20257:00 amRNSTransaction in Own Shares
2nd Dec 20254:03 pmRNSNotification of major holdings
2nd Dec 20257:00 amRNSTotal Voting Rights
2nd Dec 20257:00 amRNSTransaction in Own Shares
1st Dec 20257:00 amRNSTransaction in Own Shares
26th Nov 20257:00 amRNSNotice of Results and Presentations
25th Nov 20257:00 amRNSTransaction in Own Shares
12th Nov 20257:00 amRNSTransaction in Own Shares
11th Nov 20257:00 amRNSTransaction in Own Shares
7th Nov 20257:00 amRNSTransaction in Own Shares
5th Nov 20257:00 amRNSTransaction in Own Shares
4th Nov 20257:00 amRNSAppointment of Non-Executive Chair
4th Nov 20257:00 amRNSTransaction in Own Shares
3rd Nov 20257:00 amRNSTransaction in Own Shares
31st Oct 20254:05 pmRNSNotification of major holdings
31st Oct 20252:47 pmRNSTotal Voting Rights
31st Oct 20257:00 amRNSTransaction in Own Shares
29th Oct 20257:00 amRNSTransaction in Own Shares
28th Oct 20257:00 amRNSTransaction in Own Shares
23rd Oct 20255:07 pmRNSNotification of major holdings
15th Oct 20257:00 amRNSTrading Update
13th Oct 20257:00 amRNSTransaction in Own Shares
10th Oct 20257:00 amRNSTransaction in Own Shares
8th Oct 20257:00 amRNSTransaction in Own Shares
7th Oct 20257:00 amRNSTransaction in Own Shares
2nd Oct 20257:00 amRNSTransaction in Own Shares
1st Oct 20255:12 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.